Illicit Consumption of Drugs Creates Demand for Tough Screening Kits
Drugs of abuse testing is increasingly used in developed economies for pre-employment screening, random drug/alcohol screening, post-incident drug or alcohol screening and abstinence monitoring. Illicit drug addicts are prone to frequent job switches, less productivity, irregular presence and likely to cause workplace accidents. Several private and public employers thus continue to emphasise regulation of the workforce from drug abstinence through periodic drugs of abuse tests.
The drugs of abuse testing market is anticipated to witness notable growth due to the growing demand for drug abuse treatments, strict laws authorising alcohol and drug testing, rising drug-related mortality and increasing government initiatives. Commercial practices of drugs of abuse testing have experienced a significant change over the years to stay abreast of the new substances that are being abused. Applications of drugs of abuse testing kits have also gained attention in areas of sports, workplaces, and random screenings at checkpoints, which indicates a lucrative revenue generation opportunity for participants in drugs of abuse testing market.
Market Witnesses a Tectonic Shift from Laboratory Screening to On-the-Spot Testing
Cost-effectiveness of on-the-spot testing has led to a shift from lab-based tests for screening. Additionally, its ability to provide rapid results as compared to lab-based definitive tests has also proven positive for growth. Hence, law enforcement agencies prefer to use rapid on-the-spot screening tests. Manufacturers are also introducing innovative and user-friendly disposable products at affordable competitive prices as a push strategy among the end-users.
The urine segment has accounted for the highest revenue in 2019 and is anticipated to hold a dominant position throughout the forecast period. This is mainly due to the low cost of urine sample analysis kits and higher availability of point-of-care tests. In addition, urine as a specimen for drug testing allows for a long window of detection.
Growing Number of Drug Addicts Remains Integral to Market Growth
The growing number of people who consume alcohol and illicit drugs such as cocaine and others are one of the major drivers for the drugs of abuse testing market. Several other factors such as increased use of drug testing at an institutional level, growing, consumption and trade of illicit drugs, rise in road accident incidents and higher mortality rate are driving the growth of drugs of abuse testing market.
As per the National Institute of Drug Abuse (NIDA), around 52 million people use prescription drugs for nonmedical reasons. Technological advancements in drug screening devices, and stringent government regulations mandating drug screening will further boost the performance of drugs of abuse testing market. Despite the presence of many technologically superior products, the drugs of abuse testing market lacks the ability to detect low-dose designer drugs that continue to hamper its short-term growth. Additionally, the social stigma associated with drugs abuse testing, and legalisation of drugs are a direct threat to the steadfast growing drugs of abuse testing market. There is a severe lack of awareness of drug testing as a breach of fundamental privacy rights in certain countries that further restricts the market growth.
Developing, and Low-income Markets Struggling with Low Legal Threshold
North America region is the leading geography and poses to keep its dominance over the forecast period. The growth is primarily attributable to the government initiatives and strict legal framework. The US authorities have mandated drugs abusing tests in many critical industry verticals like defence, oil and gas and mining and Department of Transportation (DOT).
Low awareness, and inadequate social support have increased consumption of illicit drugs in developing countries in Latin America, and Africa. According to the WHO, 77% of Brazilian children are reported to consume alcohol regularly. Moreover, the aggressive marketing of tobacco, and alcohol is prominent among low-income countries. Unfortunately, legal systems in these regions are not playing an effective role to curtail these malpractices. Drugs of abuse testing market is thus expected to witness sluggish growth in these regions.
Multiple players are present, competing closely to penetrate the market deeper. Many regional players are dominating in respective geographies. Some of the most prominent players operating in drugs of abuse testing market include One Step Detect Associates, Abbott Diagnostics, Accutech, Acon Laboratories Inc., Agilent Technologies, Alfa Scientific, American Bio Medica, Beckman Coulter, Biophor Diagnostics, Bio-Rad Laboratories, Bioscan Screening Systems, Confirm Biosciences, Danaher Corp., Devon Medical Products, Elitech Group, Express Diagnostics International Inc., Hoffmann-La Roche, Ltd., Identa Corp., Lifeloc Technologies, Lifesign, Mavand Solutions, Medtest Dx, Medtox Diagnostics, and Mossman Associates.
The drugs of abuse testing market is segmented as below:
By Product and Services
By Sample Type
By End User
Key Elements Included In The Study: Global Drugs of Abuse Testing Market
Post Sale Support, Research Updates & Offerings
We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.
Under uncertainty, traditional approaches to strategic planning can be downright dangerous. True ambiguity is no basis to forecast the future – degree of risk, the magnitude of circumstances, conditions and consequences are not known or unpredictable. To avoid dangerous binary views of uncertainty; strategic posture, moves and actions through market research is the best bet.Read more